SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending due to the anticipation surrounding its inaugural Investor Day, where management is expected to detail multi-year growth strategies, share buyback programs, and the expansion of high-bandwidth memory products. Investors are closely monitoring these disclosures for long-term guidance, driving significant speculative activity and positioning ahead of the event.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging as the community highlights the stock's massive revenue growth, record backlog, and strong fiscal guidance, all of which are fueling intense discussions about a potential short squeeze. Investors are actively debating the company's valuation gap compared to AI infrastructure peers and are monitoring for a sustained break above the $40 level to trigger further momentum.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending due to strong institutional accumulation ahead of key upcoming milestones, including an August 12th investor presentation and a Q4 BLA filing for its lead prostate cancer candidate. Community discussion is heavily focused on the clinical de-risking of manufacturing processes and expectations that the company's solid clinical data will drive significant long-term value despite short-term market volatility.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as investor interest surges following the close of the Northern Data acquisition and strong Q3 revenue guidance, fueling speculation around an aggressive short squeeze. The community is actively debating the company's pivot into AI infrastructure, with many bulls pointing to massive GPU compute capacity and power assets as catalysts for a potential long-term price re-rating.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is trending as investors digest a strong earnings report and raised guidance that highlights a networking supercycle, despite an initial sell-off driven by gross margin concerns. While some in the community point to potential market manipulation or algorithmic trading as the cause for the volatility, many investors view the current price drop as a buying opportunity given the company's solid long-term AI infrastructure momentum.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as retail investors rally behind new legal maneuvers against major industry players like Micron, Super Micro, and HPE, fueling speculation about potential settlements and increased valuation. The community is actively discussing the stock's upward momentum, the strategic implications of recent licensing deals, and the expectation of future institutional interest as the company aims for a potential Nasdaq uplisting.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems is experiencing significant volatility following a second-quarter earnings report that missed revenue expectations, despite the company raising its full-year guidance. The community is sharply divided, with some investors viewing the pullback as a buying opportunity while others express skepticism over the company's valuation, profitability, and impending share lockup expirations.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is facing significant downward volatility as investors express frustration over price manipulation and the stock's failure to maintain recent gains. While the community remains divided between those betting on long-term growth from pediatric rollout and future pipeline readouts, many are actively calling for share buybacks and a potential buyout to resolve what they perceive as stagnant performance.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is currently experiencing intense market activity as investors drive a short squeeze fueled by robust quarterly earnings and upward analyst revisions. The community is heavily focused on the stock's volatility, with vocal debates between long-term supporters of its AI infrastructure thesis and those betting against the stock's rapid surge.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is experiencing extreme volatility following an earnings report that featured significant revenue growth and raised forward guidance, yet missed earnings per share expectations. The community is sharply divided, with bulls pointing to a massive backlog and scaling infrastructure as long-term catalysts, while bears and short sellers focus on the earnings miss and dilution risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mesoblast Limited (MESO) is a Great Momentum Stock: Should You Buy?

Does Mesoblast Limited (MESO) have what it takes to be a top stock pick for momentum investors? Let's find out.

PayPal, Veradermics, Alibaba And Other Big Stocks Moving Higher On Wednesday

US stocks close higher, Dow Jones up 100 points, PayPal shares rise on $53 billion acquisition proposal, other big gains from Aehr Test, Electrovaya, Robo.ai, Falcon's Beyond, Veradermics, Lucid Group, Kopin, MINISO, Mesoblast, Nexstar, Lionsgate, Karman.read more...

Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It

Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It PR Newswire NEW YORK, May 22, 2026 Issued on behalf of Conexeu Sciences Inc.Companies mentioned: Conexeu Sciences Inc. (NASDAQ...

Mesoblast (NASDAQ:MESO) Shares Cross Above Fifty Day Moving Average   - Here's Why

Mesoblast (NASDAQ:MESO) Stock Price Crosses Above Fifty Day Moving Average - Here's Why...

Mesoblast (NASDAQ:MESO) Shares Gap Up   - Should You Buy?

Mesoblast (NASDAQ:MESO) Shares Gap Up - What's Next...

Mesoblast Secures Exclusive CAR-MSC Technology License; Stock Up

(RTTNews) - Mesoblast Limited (MESO, MSB.AX) announced the acquisition of an exclusive worldwide license to a patented chimeric antigen receptor (CAR) technology platform. This innovation is designed to enhance the precision and effectiveness of Mesoblast's mesenchymal lineage st...

Insider Buying: Mesoblast (NASDAQ:MESO) Director Buys 1,586,890 Shares of Stock

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George acquired 1,586,890 shares of the company's stock in a transaction dated Thursday, April 9th. The stock was acquired at an...

Mesoblast (NASDAQ:MESO) Director Gregory George Purchases 1,586,890 Shares

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George acquired 1,586,890 shares of the firm's stock in a transaction dated Thursday, April 9th. The shares were purchased at an...

Gregory George Acquires 2,324,072 Shares of Mesoblast (NASDAQ:MESO) Stock

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George bought 2,324,072 shares of the business's stock in a transaction on Friday, April 10th. The stock was acquired at an average cost of $1.48 per share, for a total transaction of $3,439,626.56. Following the acquisition, the...

Mesoblast (NASDAQ:MESO) Director Gregory George Purchases 4,000,000 Shares

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George purchased 4,000,000 shares of the business's stock in a transaction on Saturday, April 4th. The stock was purchased at an average cost of $1.42 per share, with a total value of $5,680,000.00. Following the completion of the...

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.

Mesoblast Ltd - ADR

Mesoblast Gives Positive Update About Potential FDA Application For Heart Failure Therapy: Retail Sees ‘Inflection Point’

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

MESOMesoblast limited.

Fundamentals

Connect Stocktwits to ChatGPT

Latest MESO News